Richard Vosser

Stock Analyst at JP Morgan

(1.44)
# 3,241
Out of 4,839 analysts
10
Total ratings
57.14%
Success rate
-1.81%
Average return

Stocks Rated by Richard Vosser

Molecular Partners AG
Dec 5, 2023
Maintains: Neutral
Price Target: $6.6$4.5
Current: $3.89
Upside: +15.59%
Novo Nordisk
Jun 7, 2022
Upgrades: Overweight
Price Target: n/a
Current: $68.17
Upside: -
Sanofi
Jan 6, 2020
Upgrades: Overweight
Price Target: n/a
Current: $52.51
Upside: -